Cancer Database Query Results

Scientific Papers found: Click to Expand⟱

InA,

Lipoxygenase Inhibitory Activity of Korean Indigenous Mushroom Extracts and Isolation of an Active Compound from Phellinus baumii

Study,

Nor,

*5LO↓,

7614-

InA,

Inoscavin A, a new free radical scavenger from the mushroom Inonotus xeranticus

Study,

Nor,

*ROS↓,

33-

InA,

Inoscavin A, a pyrone compound isolated from a Sanghuangporus vaninii extract, inhibits colon cancer cell growth and induces cell apoptosis via the hedgehog signaling pathway

vitro+vivo,

Colon,

 xenograft mouse model.

HH↓, Smo↓, TumCP↓, Apoptosis↑,

7628-

Ins,

Proteomic Analysis of Anticancer Effect of Myo-inositol in Human Prostate Cancer (DU-145) Cell Line

in-vitro,

Pca,

DU145

 0.06 mg/ml

tumCV↓, annexin II↓, Cofilin↓, Rho↑, APAF1↑, TRAF2↑, Apoptosis↑, PI3K↓, Akt↓,

7617-

Ins,

miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting

in-vitro,

BC,

PI3K↓, Akt↓, TumMeta↓, miR-125b↝, IP6K1↓,

7616-

Ins,

A phase I study of myo-inositol for lung cancer chemoprevention

Trial,

Nor,

*Dose↝, *toxicity↝, *BP↓,

7615-

Ins,

A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia

*Dose↝, *IL6↓, *PI3K↓,

7630-

Ins,

Modulation of both Insulin Resistance and Cancer Growth by Inositol

Review,

Var,

Review,

Diabetic,

*IRes↓, *AntiDiabetic↑, *glucose↝, AntiCan↑, PI3K↓, Akt↓, Glycolysis↓, STK11/LKB1↑, *FASN↓, *LDL↓, *FFA/NEFA↓, *ROS↓, ROS↑, IGF-1↓,

7703-

Ins,

Inositol hexaphosphate-induced cellular response in myeloid leukemia cells is mediated by nicotinamide adenine dinucleotide phosphate oxidase activation

in-vitro,

AML,

PLB-985

TumCG↓, TumCD↑, Diff↑, NOX2↑, ROS↑,

7629-

Ins,

Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol

in-vivo,

Lung,

Cancer-prone transgenic mice with oncogenic Kras expressed

AntiCan↑, TumVol↓, PI3K↓, IL6↓, p‑STAT3↓, chemoPv↑,

7648-

Ins,

Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositol

in-vivo,

Liver,

AntiCan↑, Dose↝, Risk↓, chemoPv↑,

7647-

Ins,

Chemoprevention of pulmonary carcinogenesis by myo-inositol

Review,

Lung,

AntiTum↑,

7643-

Ins,

IP6,

Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical stud

Trial,

BC,

14 patients involved in the study

RBC↑, QoL↑, Synergy↑, Imm↑, ChemoSen↑, chemoP↑, Dose↝,

7636-

Ins,

Myo-Inositol: Pharmacokinetics, Biological Functions, and Therapeutic Potential in Liver Protection: Insights from Preclinical Models

*glucose↝, *lipid-P↓, *ROS↓, *BioAv↑, *hepatoP↑, *Inflam↓, *MMP↑, *ATP↑, *GutMicro↑, *Dose↝, *Half-Life↝, *BioAv↑, *Synergy↑, *hepatoP↑, *SOD↑, *Catalase↑, *Casp3↓, *ALAT↓, *AST↓, *AMPK↑, *SREBP1/SREBF1↑, *NA↑,

7634-

Ins,

Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors

Trial,

Nor,

18 healthy volunteers received orally 6000 mg MI

*BioAv↓,

7633-

Ins,

Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use

Trial,

Nor,

20 healthy volunteers who received different doses of MI powder and MI soft gelatin capsules.

*BioAv↑, *toxicity↓,

7635-

Ins,

The Role of Inositols in Endocrine and Neuroendocrine Tumors

Review,

Thyroid,

*Dose↝, VEGF↓, Imm↑, NK cell↑, Synergy↑, PI3K↓, Akt↓, EMT↓, MAPK↓, Wnt↓, NF-kB↓, IRes↓, *ROS↓, TumVol↓, *TSHR↓,

7637-

Ins,

Investigating the mechanism of inositol against paclitaxel chemoresistance on triple-negative breast cancer by using 7T multiparametric MRI and mitochondrial changes

vitro+vivo,

BC,

4T1

BALB/c mice aged 6–8 weeks were subcutaneously inoculated with PTX-resistant 4T1 cells

TumVol↓, Dose↝, *toxicity↓, AMPK↓, Ki-67↓,

7638-

Ins,

d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI)

Review,

Nor,

*Insulin↝, *CYP19↓, *Dose↝, *Dose↝, *other↝, *Insulin↓, *IRes↓, *Obesity↓, *BioAv↝,

7639-

Ins,

Myo-Inositol Reverses TGF-β1-Induced EMT in MCF-10A Non-Tumorigenic Breast Cells

in-vitro,

Nor,

MCF10

EMT↓, E-cadherin↑, AntiCan↑, MMP9↓,

7641-

Ins,

Overview of Inositol and Inositol Phosphates on Chemoprevention of Colitis-Induced Carcinogenesis

Review,

CRC,

AntiCan↑, p‑Akt↓, TF-Ag↓, *PI3K↓, *AP-1↓, *DNArepair↑, *BioAv↑, *BBB↑, *other↑, *PGE2↓,

7631-

Ins,

IP6,

Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate

Review,

Var,

other↑, p‑pRB↓, TumCCA↑, PI3K↓, Akt↓, ERK↓, NF-kB↓, COX2/PTGS2↓, PGE2↓, PSEN1/PS1↓, EMT↓, Wnt↓, β-catenin/ZEB1↓, NOTCH1↓, N-cadherin↓, Snail↓, E-cadherin↑, fascin↓, Cofilin↓, MMPs↓, ROCK1↓, Dose↝, other↝, selectivity↑, *ROS↓, *lipid-P↓, ROS↑, NK cell↑, Imm↑, TNF-α↓, ChemoSen↑, Dose↑, toxicity↓, QoL↑, chemoP↑, OS↑, Dose↝, Insulin↓, glucose↝, lipoGen↓, Synergy↑,

7632-

Ins,

The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor

Review,

Var,

AMPK↑, AntiCan⇅, p‑Akt↓, PI3K↓,

7672-

iod,

Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study

Trial,

BC,

 30 patients diagnosed with Early stage breast cancer were enrolled in the study and 23 completed the treatment

Dose↝, OS↑, TumCI↓, Apoptosis↑, EstroRS/ERS↑, Synergy↑, *cardioP↑, *antiOx↑, *Inflam↓,

7671-

iod,

Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line

in-vitro,

BC,

MCF7

uptake and antiproliferative effect of two different chemical forms of iodine, iodide (I-) and molecular iodine (I2), in MCF-7 cells

TumCP↓,

7673-

iod,

Chemo,

Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study

Trial,

BC,

(I2), alone and in combination with the neoadjuvant therapy 5-fluorouracil/epirubicin/cyclophosphamide or taxotere/epirubicin (FEC/TE) in women with Early (stage II) and Advanced (stage III) breast cancer

Dose↝, *chemoP↑,

7674-

iod,

Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway

in-vitro,

BC,

AntiTum↑, selectivity↑, MMP↓, antiOx↑, Thiols↓, Bcl-2↓, BAX↑, eff↓, Casp↑, ROS↓, ROS↑, Cyt‑c↑, AIF↑,

7676-

iod,

Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)

in-vivo,

BC,

rats

TumCP↓, Apoptosis↑, Dose↝, other↑, BloodF↓, VEGF↓, UroPA↓, PPARα↓, DR4↑, Casp3↑, PPARγ↑, antiNeop↑, Risk↓, 6IL↑,

7677-

iod,

Activation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone

in-vitro,

BC,

MCF7

TumCP↓, 6IL↑, PPARγ↑, AntiCan↑,

7678-

iod,

Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects

in-vitro,

Nor,

MCF12A

in-vitro,

BC,

MCF7

TumCCA↑, selectivity↑, 6IL↑, eff↑,

7679-

iod,

Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin

in-vivo,

BC,

MCF7

AntiTum↑, tumCV↓, Apoptosis↑, Bax:Bcl2↑, Bcl-2↓, MDR1↑, PPARγ↑, CD44↓,

7680-

iod,

doxoR,

Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection

vitro+vivo,

BC,

rats

antiNeop↑, antiOx↑, Dose↝, TumVol↓, PCNA↓, Weight↑, cardioP↑, ChemoSen↑,

7681-

iod,

metroC,

Molecular Iodine Improves the Efficacy and Reduces the Side Effects of Metronomic Cyclophosphamide Treatment against Mammary Cancer Progression

in-vivo,

BC,

tumCV↓, Imm↑, chemoP↑, Weight↑, TumCG↓, VEGF↓, survivin↓, ChemoSen↑,

7682-

iod,

Molecular Iodine Induces Anti- and Pro-Neoplastic Effects in Prostate Cancer Models

in-vitro,

Pca,

LNCaP

TRAMP mice (transgenic adenocarcinoma of the mouse prostate

in-vitro,

Pca,

DU145

in-vitro,

Pca,

PC3

PPARγ↑, antiNeop↑, TumCD↑, TumCI↓, AntiCan⇅, antiOx↑, Inflam↓, Apoptosis↑, tumCV↓,

7683-

iod,

Se,

Prediagnostic serum iodine and selenium in relation to breast cancer survival

Study,

BC,

 918 patients with breast cancer were included in this study. The mean(standard deviation) follow-up time was 11.4(6.0) years.

OS↑, other⇅,

7684-

iod,

Molecular iodine impairs chemotherapy resistance and adverse effects in breast cancer treatments

Trial,

BC,

Early group, 22 women were treated with I2 (3 mg/day) or placebo (colored water) for 15-30 days before surgery . advanced group, 16 patients received I2 or placebo, along with Neo treatment (30-90 days)

Dose↝, OS↑, antiNeop↑, eff↑,

7685-

iod,

Could iodine be the missing micronutrient in breast cancer development?

Review,

BC,

Risk↓, other↝, other↝, BioAv↝,

7686-

iod,

Molecular Iodine Exhibited Differential Antiproliferative Actions in Progenitor and Stem Populations from Chemoresistant Cancer Cells

vitro+vivo,

BC,

MCF7

zebrafish xenograft

PPARγ↑, Apoptosis↑, Bax:Bcl2↑, CSCs↓, NRF2↑, tumCV↓, TumCI↓,

7687-

iod,

ESWT,

Shock Wave Application Increases the Antineoplastic Effect of Molecular Iodine Supplement in Breast Cancer Xenografts

in-vivo,

BC,

MDA-MB-231

fifty-six female athymic homozygous nude mice

antiNeop↑, CSCsMark↓, CD44↓, SOX2↓, HIF-1↓, VEGF↓, Dose↝, Dose↝, EPR↝, PPARγ↑,

7688-

iod,

CEL,

Iodine prevents the increase of testosterone-induced oxidative stress in a model of rat prostatic hyperplasia

in-vivo,

Pca,

rat

TumCP↓, ROS↓, NOS2↓, COX2/PTGS2↓,

7689-

iod,

Uptake and antitumoral effects of iodine and 6-iodolactone in differentiated and undifferentiated human prostate cancer cell lines

in-vitro,

Nor,

RWPE-1

in-vitro,

Pca,

LNCaP

vitro+vivo,

Pca,

DU145

nude mice xenotransplanted

Bax:Bcl2↑, Casp↑, TumCG↓,

2172-

iod,

A prospective study of iodine status, thyroid function, and prostate cancer risk: follow-up of the First National Health and Nutrition Examination Survey

Study,

Pca,

Risk↓,

7661-

IP,

Enhancement of carbohydrate metabolism by probiotic and prebiotic intake promotes short-chain fatty acid production in the gut microbiome: a randomized, double-blind, placebo-controlled crossover trial

Trial,

Nor,

randomized, double-blind, crossover study was conducted with 120 participants

*PA↑, *Buty↑, *GutMicro↑, *SCFAs↑,

7652-

IP,

Inulin prebiotic reinforces host cancer immunosurveillance via ɣδ T cell activation

in-vivo,

Melanoma,

B16-F10

three preclinical tumor-bearing mouse models.

GutMicro↑, Imm↑, CD4+↑, CD8+↑, TumCG↓,

7653-

IP,

Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel

in-vivo,

Var,

mice

GutMicro↑, T-Cell↑, AntiTum↑, Synergy↑, TumCG↓,

7654-

IP,

Dietary Supplementation of Inulin Contributes to the Prevention of Estrogen Receptor-Negative Mammary Cancer by Alteration of Gut Microbial Communities and Epigenetic Regulations

in-vivo,

BC,

 inulin-supplemented diet on the prevention of estrogen receptor-negative mammary carcinoma in a transgenic mouse model

TumCG↓, GutMicro↑, PA↑, HDAC2↓, HDAC8↓, DNMT3B↓, Akt↓, PI3K↓, NF-kB↓, Dose↝, Dose↝,

7655-

IP,

SFN,

Combined Phytochemical Sulforaphane and Dietary Fiber Inulin Contribute to the Prevention of ER-Negative Breast Cancer via PI3K/AKT/MTOR Pathway and Modulating Gut Microbial Composition

in-vivo,

BC,

mice

Dose↝, TumCG↓, TumW↓, GutMicro↑, HDAC↓, DNMTs↓, Akt↓, PI3K↓, mTOR↓, NF-kB↓, TumCCA↑, cl‑Casp3↑, cl‑Casp7↑, CDK2↓, CDK4↓, Risk↓, Dose↝,

7656-

IP,

Inulin Modulates Gut Microbiota and Increases Short-Chain Fatty Acids Levels to Inhibit Colon Tumorigenesis in Rat Models: A Systematic Review and Meta-Analysis

Review,

CRC,

GutMicro↑, chemoPv↑, SCFAs↑,

7657-

IP,

Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats

in-vivo,

Var,

rats

Dose↝, AntiTum↑,

7658-

IP,

Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition

in-vivo,

CRC,

rats

AntiTum↑, GutMicro↑,

Showing Research Papers: 4901 to 4950 of 8582
Prev Page 99 of 172 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8582

Pathway results for Effect on Cancer / Diseased Cells:

Ingredients & Constituents(tgid=25) ⓘ

Api↑, 1, Ingr?, 4, Ingr↑, 1, Ingr↝, 5,
Total Targets: 2887

Pathway results for Effect on Normal Cells:

NA, unassigned(tgid=0) ⓘ

NA↓, 1, NA↑, 2, NA↝, 2,

Redox & Oxidative Stress(tgid=1) ⓘ

3-NT↓, 1, 4-HNE↓, 6, antiOx?, 3, antiOx↓, 44, antiOx↑, 788, i-antiOx↑, 1, mt-antiOx↑, 1, ARE↑, 13, ARE↝, 1, Bil↓, 5, Bil↑, 2, Catalase↓, 9, Catalase↑, 254, Catalase↝, 2, Copper↓, 4, CoQ10↑, 1, DPPH↓, 2, DUOX1↓, 1, Fenton↓, 8, GCLC↑, 7, GCLC↝, 1, GCLM↑, 5, GCLM↝, 1, GPx↓, 6, GPx↑, 185, GPx↝, 1, GPx∅, 1, GPx1↑, 11, GPx3↑, 1, GPx4↓, 2, GPx4↑, 22, GPx4∅, 1, GSH↓, 17, GSH↑, 317, GSH⇅, 1, GSH∅, 2, GSH/GSSG↓, 1, GSH/GSSG↑, 3, GSR↓, 3, GSR↑, 38, GSS↑, 2, GSSG↓, 7, GSSG∅, 1, GSTs↓, 5, GSTs↑, 51, H2O2↓, 26, H2O2↑, 2, H2O2∅, 2, HDL↓, 3, HDL↑, 19, HDL∅, 3, HNE↓, 3, HNE↑, 1, HO-1?, 1, HO-1↓, 9, HO-1↑, 228, HO-1⇅, 1, HO-1↝, 1, HO-1∅, 1, HO-2↓, 1, hyperG↓, 2, Iron↓, 14, Iron↑, 2, Iron↝, 2, Iron∅, 1, i-Iron↓, 3, i-Iron↑, 1, Keap1↓, 22, Keap1↑, 2, Keap1↝, 2, ox-Keap1↑, 1, lipid-P?, 3, lipid-P↓, 247, lipid-P↑, 7, mt-lipid-P↓, 1, lipidDe↓, 1, MDA↓, 252, MDA↑, 12, MDA∅, 1, MPO↓, 29, MPO↑, 2, MPOD↑, 3, NADH↓, 1, NADPH/NADP+↑, 1, NFE2L2↓, 1, NOX↓, 6, NOX↑, 1, NOX1↓, 1, NOX2↓, 3, NOX4↓, 13, NQO1↑, 57, NQO1↝, 2, NQO1∅, 1, Nrf1?, 1, Nrf1↓, 1, Nrf1↑, 9, NRF2?, 1, NRF2↓, 18, NRF2↑, 407, NRF2⇅, 1, NRF2↝, 2, NRF2∅, 2, p‑NRF2↑, 2, ONOO↓, 1, PCO↓, 1, Prx↓, 1, Prx↑, 7, Prx4∅, 1, PrxII↑, 1, RNS↓, 11, ROMO1↑, 1, ROS?, 9, ROS↓, 1076, ROS↑, 58, ROS⇅, 13, ROS↝, 3, ROS∅, 26, i-ROS↑, 1, mt-ROS?, 1, mt-ROS↓, 10, mt-ROS↑, 4, RPM↑, 1, RPM↝, 1, SAM-e↓, 3, SAM-e↑, 1, selenoP↑, 20, SOD?, 2, SOD↓, 16, SOD↑, 368, SOD↝, 2, mt-SOD↑, 1, SOD1↓, 2, SOD1↑, 18, SOD2↓, 2, SOD2↑, 22, TAC↑, 48, TAC∅, 1, TBARS↓, 11, TBARS↑, 1, Thiols↓, 1, Thiols↑, 5, TOS↓, 3, TOS↑, 2, Trx↓, 2, Trx↑, 10, Trx1↑, 6, TrxR↓, 2, TrxR↑, 4, TrxR1↑, 4, UCPs↑, 2, UCPs↝, 1, uricA↓, 8, VitC↑, 16, VitE↓, 1, VitE↑, 8, xCT/SLC7A11↓, 2, xCT/SLC7A11↑, 5,

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1, Ferritin↑, 2, FPN↑, 1, FTH1↓, 1, FTH1↑, 2, FTL↓, 1, IronCh↓, 1, IronCh↑, 55, IronCh↝, 1, Mets↝, 1, NCOA4↝, 1, TfR1/CD71↓, 5, TfR1/CD71↑, 1, Zn2+↓, 1,

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↓, 1, compI↓, 2, compI↑, 2, compII↑, 1, compIII↓, 1, compIII↑, 2, compV↑, 1, DRP1/DNM1L↓, 11, DRP1/DNM1L↑, 3, p‑DRP1/DNM1L↝, 1, EGF↑, 1, ETC↓, 4, ETC↑, 3, ETC↝, 2, FIS1↓, 12, FIS1↑, 3, HSP60/HSPD1↓, 1, Insulin↓, 9, Insulin↑, 9, Insulin↝, 1, MCU↓, 1, MFN1↓, 1, MFN1↑, 3, MFN1↝, 1, MFN2↓, 2, MFN2↑, 8, MFN2↝, 1, mitResp↓, 3, mitResp↑, 10, mtDam↓, 35, mtDam↑, 1, NGB↑, 1, OCR↓, 4, OCR↑, 7, mt-OCR↑, 1, OPA1↓, 2, OPA1↑, 4, OXPHOS↓, 3, OXPHOS↑, 9, PDH↑, 1, PGC-1α↓, 3, PGC-1α↑, 33, PGC-1α↝, 2, PINK1↓, 1, PINK1↑, 4, SIRT3↑, 16, TFAM↑, 2, UCP1↓, 1, VDAC1↓, 1,

Core Metabolism/Glycolysis(tgid=4) ⓘ

12-HETE↓, 1, 12LOX↓, 10, 12LOX↑, 1, 15-LOX/ALOX15↓, 1, 3MST/MPST↑, 1, 5-HETE↓, 1, 5LO↓, 29, 5LO↝, 1, ACADS/SCAD↑, 1, ACC↓, 3, ACC↑, 3, p‑ACC↑, 1, mt-ACC⇅, 1, Acetyl-CoA↓, 2, Acetyl-CoA↑, 5, ACLY↓, 2, ACLY∅, 1, AcOH↑, 2, ACSL4↓, 4, ACSL4∅, 1, adiP↓, 2, adiP↑, 8, e-ADO↑, 1, ALAT?, 1, ALAT↓, 96, ALAT↑, 3, ALAT∅, 4, ALDOA↑, 1, ALDOC↑, 1, AMP↓, 1, AMPK↓, 4, AMPK↑, 75, AMPK⇅, 1, AMPK↝, 1, p‑AMPK↑, 8, ATP↓, 6, ATP↑, 56, ATP↝, 1, ATP∅, 1, mt-ATP↑, 1, BMAL1↑, 1, Buty↑, 4, cAMP↑, 9, CBS↑, 1, Cit/L-Cit↝, 1, cPLA2↓, 1, CPT1A↑, 1, CRM↓, 1, CRM↑, 11, CYP51/14LDM↑, 1, cytoP450↓, 2, DGAT1↓, 1, DHA↑, 3, DHODH↓, 1, ECAR↓, 5, ECAR↑, 2, ECAR∅, 1, Eic↓, 1, FABP4↓, 2, FAM↑, 1, FAO↓, 2, FAO↑, 7, mt-FAO↑, 1, FASN↓, 9, FFA/NEFA↓, 2, FFA/NEFA↝, 1, G6PD↑, 3, GAPDH↑, 1, GDH↓, 1, glucoNG↓, 3, glucose↓, 32, glucose↑, 3, glucose↝, 6, glucose∅, 1, GlucoseCon↓, 4, GlucoseCon↑, 22, GlutMet↑, 1, glyC↓, 1, Glycolysis↓, 9, Glycolysis↑, 10, Glycolysis↝, 4, GPI↑, 1, GSK‐3β↓, 48, GSK‐3β↑, 9, GSK‐3β↝, 1, p‑GSK‐3β↓, 2, p‑GSK‐3β↑, 8, H2S↑, 4, ac‑Histones↑, 1, HK1↑, 1, HK2↓, 8, HK2↑, 6, HMG-CoA↓, 3, KeyT↑, 5, KeyT↝, 2, lactateProd↓, 7, LDHA↓, 4, LDHA↑, 5, LDHB↑, 1, LDL↓, 71, lipidLev↓, 6, lipoGen↓, 2, LTB4↓, 1, LTC4↓, 2, MATs↓, 1, NAD↓, 1, NAD↑, 8, NAD↝, 1, NADH:NAD↑, 1, NADPH↓, 20, NADPH↑, 17, NADPH∅, 1, NH3↓, 3, NH3↑, 1, ODC1↝, 1, PA↑, 2, PDK1 / PDPK1↓, 2, p‑PDK1 / PDPK1↓, 1, PDKs↓, 2, PDKs↑, 1, PFK↓, 3, PFK↑, 1, PFK1↓, 1, PFK2↓, 1, PFKL↑, 3, PFKM↑, 2, PFKP↓, 1, PFKP↑, 1, PGC1A↑, 2, PGM1?, 1, PIP3↑, 1, PKM1↑, 2, PKM2↓, 18, PKM2↑, 8, PLA2↓, 2, polyA↝, 1, PONs↓, 1, PONs↑, 1, PPP↓, 2, SCD1↓, 1, SCFAs↑, 4, SCFAs∅, 1, SIRT1↓, 4, SIRT1↑, 79, SIRT1↝, 1, SIRT1∅, 1, SIRT2↑, 3, SREBF2↓, 1, SREBP1/SREBF1↓, 8, SREBP1/SREBF1↑, 1, SREBP2↓, 1, SREBP2↑, 1, TCA↑, 1, Warburg↓, 1,

Cell Death(tgid=5) ⓘ

AIF↓, 4, AIF↑, 1, APAF1↓, 2, Apoptosis↓, 154, Apoptosis↑, 5, Apoptosis∅, 2, mt-Apoptosis↓, 1, ASC?, 1, ASC↓, 5, ASK1↓, 2, BAD↓, 3, BAX↓, 60, BAX↑, 8, Bax:Bcl2↓, 13, Bax:Bcl2↑, 3, Bax:Bcl2↝, 1, Bcl-2↓, 10, Bcl-2↑, 51, Bcl-2↝, 1, Bcl-2∅, 1, Bcl-xL↓, 1, Bcl-xL↑, 2, BNIP3↓, 1, Casp↓, 4, Casp1?, 1, Casp1↓, 14, cl‑Casp1↓, 2, proCasp1↓, 2, Casp12↓, 7, Casp3?, 1, Casp3↓, 93, Casp3↑, 10, Casp3∅, 2, cl‑Casp3↓, 17, cl‑Casp3↑, 1, proCasp3↓, 2, Casp6↓, 1, Casp7↓, 1, Casp8↓, 3, Casp8↑, 1, cl‑Casp8↑, 3, Casp9↓, 28, Casp9↑, 4, Casp9∅, 1, cl‑Casp9↓, 4, cl‑Casp9↑, 1, cellD↓, 1, Cyt‑c↓, 23, Cyt‑c↑, 5, Cyt‑c∅, 4, Fas↓, 6, Fas↑, 2, FasL↓, 1, Ferroptosis↓, 29, Ferroptosis↑, 4, GranB/GZMB↓, 1, GRP58↓, 1, GSDMD?, 1, GSDMD↓, 3, HEY1↑, 1, IAP1↓, 1, iNOS↓, 130, iNOS↑, 6, MLKL↓, 1, necrosis↓, 4, p38↓, 21, p38↑, 6, p‑p38↓, 12, Pyro?, 1, Pyro↓, 5, RIP1↓, 1, survivin↓, 1, TUNEL↓, 1, YAP/TEAD↑, 2,

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1, Akt↓, 28, Akt↑, 68, Akt↝, 3, p‑Akt↓, 10, p‑Akt↑, 18, e-Akt↑, 1, AKT1↓, 2, AKT1↑, 1, p‑AKT1↑, 1, AMPKα↑, 2, CaMKII ↓, 2, CK2↓, 1, CK2↑, 1, CREB↓, 3, CREB↑, 30, CREB∅, 1, p‑CREB↑, 13, DYRK1A↓, 2, EGFR↓, 3, ERK↓, 27, ERK↑, 30, p‑ERK↓, 11, p‑ERK↑, 11, e-ERK↑, 1, HCAR2↑, 1, HER2/EBBR2↓, 1, HGF/c-Met↑, 2, Hippo↑, 1, IGF-1R↓, 1, IGFR↓, 1, IKKα↓, 4, IKKα↑, 1, p‑IKKα↓, 4, IκB?, 1, IκB↓, 2, IκB↑, 3, p‑IκB↓, 1, JAK↓, 4, p‑JAK1↓, 1, JAK2↓, 4, JAK2↑, 4, p‑JAK2↓, 2, JNK↓, 30, JNK↑, 4, p‑JNK↓, 13, p‑JNK↑, 4, p‑LIMK1↑, 1, LPAR1/EDG2↑, 1, MAPK?, 1, MAPK↓, 66, MAPK↑, 13, MAPK↝, 4, p‑MAPK?, 1, p‑MAPK↓, 3, MEK↓, 1, p‑MEK↓, 1, p‑MEK↑, 1, p‑MKK4↑, 1, Mst1↓, 2, mTOR↓, 25, mTOR↑, 17, mTOR↝, 2, p‑mTOR↓, 8, p‑mTOR↑, 3, p‑p70S6↓, 1, P70S6K↓, 3, p‑P70S6K↓, 1, p‑P70S6K↑, 1, PDGFR-BB↓, 2, PDGFR-BB↑, 1, PDGFRB↓, 1, PFKFB2↓, 1, PI3K↓, 25, PI3K↑, 53, PI3K↝, 2, p‑PI3K↓, 3, p‑PI3K↑, 1, PKA↑, 7, PKCδ?, 1, PKCδ↓, 4, PKCδ↑, 8, p‑PKCδ↑, 1, PP2A↑, 9, PROKR1↑, 1, PROKR2↑, 1, PTEN↓, 8, PTEN↑, 6, p‑PTEN↓, 1, p‑PTEN↑, 1, PTP1B↓, 2, Raf↓, 1, RAS↓, 2, RKIP↑, 1, Sp1/3/4↓, 6, Sp1/3/4↑, 1, Src↓, 1, STAT↓, 5, STAT3?, 1, STAT3↓, 18, STAT3↑, 6, STAT3↝, 1, p‑STAT3↓, 4, p‑STAT3↑, 1, STAT4↓, 1, STAT5↓, 1, STAT6↓, 1, STEP↓, 1, STK11/LKB1↑, 1,

Transcription & Epigenetics(tgid=7) ⓘ

Ac-histone H3↑, 1, AntiThr↑, 22, ATF2↑, 1, ATF4↓, 8, ATF4↑, 1, cJun↓, 5, p‑cJun↓, 5, cMyc↓, 2, cMyc↑, 1, p‑cMyc↑, 1, DNMT1↓, 6, DNMT3A↓, 3, DNMT3A↑, 1, DNMTs↓, 3, FOXO↑, 3, FOXO1↑, 2, FOXO1↝, 1, FOXO3?, 1, FOXO3↑, 7, H3↑, 1, ac‑H3↑, 1, H3K9↓, 1, H4↑, 1, ac‑H4↑, 1, HATs↓, 4, HDAC↓, 15, HDAC↑, 2, HDAC1↓, 2, HDAC2↓, 5, HDAC3↓, 4, HOTAIR↑, 1, KLF4↑, 1, MEF2D↑, 1, miR-107↑, 1, miR-155↓, 1, miR-22↑, 1, miR-23a-3p↓, 1, miR-29b↑, 1, miR-34a↓, 1, miR-34b-5p↓, 1, n-MYC↑, 1, OCT4↓, 1, other?, 24, other↓, 70, other↑, 131, other⇅, 2, other↝, 178, other∅, 6, PhotoS↑, 1, RUNX2↑, 2, RUNX2∅, 1, SOX18↑, 1, SOX2↑, 2, SOX9↑, 2, SUV39H↓, 1, TCF-4↓, 1, tumCV↓, 5, tumCV↑, 1, tumCV∅, 1,

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↓, 5, ChemChap↓, 1, ChemChap↑, 2, CHOP/DDIT3↓, 21, CHOP/DDIT3↑, 2, eIF2α↓, 3, p‑eIF2α↓, 3, cl‑eIF2α↑, 1, ER Stress↓, 53, ER Stress↑, 2, GRP78/BiP↓, 28, GRP78/BiP↑, 4, GRP94↑, 1, HSF1↑, 2, HSP27↓, 1, HSP27↑, 1, HSP70/HSPA5↓, 1, HSP70/HSPA5↑, 18, HSP70/HSPA5↝, 1, HSP90↓, 2, HSP90↑, 3, HSPs↓, 1, HSPs↑, 6, HSPs↝, 1, IRE1↓, 7, NQO2↑, 1, PDI↓, 1, PERK↓, 8, p‑PERK↓, 2, p‑PERK↑, 1, UPR↓, 5, UPR↑, 3, XBP-1↓, 4,

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↓, 1, ATG5↓, 1, ATG5↑, 2, ATG7↓, 1, autophagy↓, 2, autophagy↑, 1, autophagy↝, 1, Beclin-1/ATG6↓, 6, Beclin-1/ATG6↑, 11, CTSZ↓, 1, CTSZ↝, 1, LC3‑Ⅱ/LC3‑Ⅰ↓, 1, LC3‑Ⅱ/LC3‑Ⅰ↑, 3, LC3A↑, 1, LC3B↓, 1, LC3B↑, 3, LC3II↓, 2, LC3II↑, 5, LC3s↓, 1, lysosome↑, 1, MitoP↓, 1, MitoP↑, 7, p62↓, 9, p62↑, 7, PARK2↑, 7, TFEB↑, 1, ULK1/ATG1↑, 1,

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 1, ATR↑, 1, DNAdam↓, 61, DNAdam↑, 3, DNAdam∅, 1, DNArepair↑, 6, importin α/β↓, 1, p16↓, 2, P53↓, 12, P53↑, 7, P53↝, 1, PARP↓, 3, PARP↑, 1, PARP∅, 1, p‑PARP↓, 1, cl‑PARP↓, 2, cl‑PARP↑, 2, PARP1↓, 1, cl‑PARP1↓, 1, PCNA↓, 4, PCNA↑, 1, RAD51↓, 1, SIRT6↑, 3, Telomerase↓, 1, TOP2↑, 1, TP53↑, 1, γH2AX↓, 1, p‑γH2AX↓, 1,

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 1, CDK2↓, 2, CDK4↓, 1, CDK5↓, 9, cellSen↓, 1, cellSen↑, 1, cycA1/CCNA1↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 4, cycE/CCNE↓, 1, cycE/CCNE↑, 1, E2Fs↑, 2, GADD34↓, 1, GADD45A↑, 1, Ki-67↓, 4, Ki-67↑, 2, P21↓, 6, P21↑, 6, RB1↓, 1, TumCCA↑, 8,

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↑, 1, BMP2↑, 3, BMPs↓, 1, BMPs↑, 2, CD133↑, 1, CD34↑, 1, CEBPA↓, 2, cFos↓, 1, cFos↑, 1, CHIP↑, 1, Choline↑, 3, CLOCK↝, 2, Diff↓, 2, Diff↑, 14, Diff↝, 2, EP2↓, 1, EP2↑, 1, EP300↓, 2, FGF↑, 7, GH↑, 3, Gli1↑, 1, HH↓, 2, HMGCR↓, 2, IGF-1↓, 9, IGF-1↑, 16, IGFBP1↑, 1, IGFBP3↓, 1, IGFBP3↑, 1, Jun↓, 1, Jun↑, 1, Ki-67↓, 4, Ki-67↑, 2, MSCs↑, 1, mTORC1↓, 3, Nestin↑, 1, neuroG↑, 17, NOTCH↓, 1, NOTCH↑, 1, NOTCH1↑, 2, p300↓, 1, Shh↓, 1, Shh↑, 1, STAT1↓, 1, p‑STAT1↓, 1, TumCG↓, 4, TumCG↑, 1, TumCG∅, 1, TumCP↓, 9, TumCP↑, 1, tyrosinase↓, 2, Wnt↓, 3, Wnt↑, 4, Wnt/(β-catenin)↓, 1, Zn2+↓, 1,

Migration(tgid=13) ⓘ

ACTA2↓, 1, AntiAg↓, 3, AntiAg↑, 97, AntiAg∅, 3, AP-1↓, 18, AP-1↑, 1, ARG1/2↑, 2, mt-ATPase↑, 1, BACH1↓, 1, Ca+2?, 3, Ca+2↓, 47, Ca+2↑, 20, Ca+2↝, 14, Ca+2∅, 1, p‑Ca+2↓, 1, i-Ca+2↓, 2, mt-Ca+2↓, 1, cal2↓, 5, Cartilage↑, 11, p‑Cofilin↓, 1, p‑Cofilin↑, 1, COL1↓, 6, COL1↑, 2, COL1∅, 1, COL1A1↓, 1, COL2A1↑, 2, COL3A1↓, 3, E-cadherin↓, 1, E-cadherin↑, 7, EMT↓, 7, EMT↑, 2, F-actin↓, 1, F-actin↑, 1, FAK↑, 2, Fibronectin↓, 2, Fibrosis↓, 1, FLRT2↑, 1, FNDC5↑, 1, GIT1↑, 1, heparanase↑, 1, ITGA5↓, 1, ITGB1↓, 1, ITGB1↑, 1, LAMs↑, 1, LRP1↑, 3, p‑MLC2/MYL9↑, 1, MMP-10↓, 1, MMP-10↝, 1, MMP1↓, 5, MMP11↑, 1, MMP13↓, 8, MMP2↓, 14, MMP2↑, 6, MMP3↓, 5, MMP3↑, 2, MMP7↓, 1, MMP9↓, 32, MMP9↑, 6, MMPs↓, 9, MMPs↑, 3, MUC1↑, 3, MYPT1 / PPP1R12A↑, 1, p‑MYPT1 / PPP1R12A↑, 1, N-cadherin↓, 1, N-cadherin↑, 2, Na+↑, 2, Na+↝, 1, Netrins↑, 1, NFAM1↑, 1, NFAT↓, 1, NFAT↑, 2, OPN↑, 1, PAI-1/SERPINE1↓, 1, PDGF↓, 1, PDGF↑, 1, PROK2↑, 1, proline↝, 1, Rac1↑, 1, p‑Rac1↓, 1, Rho↓, 7, ROCK1↓, 7, ROCK1↑, 1, Sema3A/PlexinA1↑, 1, serineP↓, 1, SLIT2↑, 1, Smad1↑, 1, p‑Smad1↑, 1, SMAD2↓, 1, p‑SMAD2↓, 3, SMAD3↓, 3, p‑SMAD3↓, 1, p‑SMAD3↑, 1, SMAD4↑, 1, SMAD5↑, 1, p‑SMAD5↑, 1, Smad7↑, 2, Snail↓, 1, Snail↑, 1, SPARC↓, 1, STAC2↑, 1, p‑T-cadherin↓, 2, TG2/TGase↓, 4, TGF-β↓, 21, TGF-β↑, 12, TGF-β1↓, 6, TGF-β1↑, 4, TIMP1↓, 5, TIMP1↑, 3, TIMP2↑, 3, TregCell↑, 1, TumCI↓, 2, TumCI∅, 1, TumCMig↓, 3, TumCMig↑, 1, TumCMig∅, 1, TumMeta↓, 2, Twist↑, 1, TXNIP↓, 8, TXNIP↑, 2, Tyro3↓, 1, uPA↓, 1, Vim↓, 9, Vim↑, 1, Zeb1↓, 1, α-SMA↓, 19, α-SMA↑, 1, α-SMA↝, 1, α-tubulin↓, 2, β-catenin/ZEB1↓, 4, β-catenin/ZEB1↑, 8, β-catenin/ZEB1↝, 1,

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG?, 1, angioG↓, 14, angioG↑, 26, angioG↝, 1, CD31/PECAM-1↓, 2, CD31/PECAM-1↑, 3, E-sel↓, 6, ECM/TCF↑, 1, EGR4↑, 1, Endoglin↑, 1, eNOS↓, 2, eNOS↑, 7, p‑eNOS↑, 2, HIF-1↓, 1, Hif1a↓, 19, Hif1a↑, 14, Hif1a↝, 1, Hif1a∅, 2, HIF2a↑, 1, Hypoxia↓, 1, LOX1↓, 2, NO?, 1, NO↓, 110, NO↑, 17, NPY↑, 1, P-sel↓, 1, REL↑, 1, TXA2↓, 8, VCAM-1↓, 19, VEGF↓, 22, VEGF↑, 31, VEGFR2/KDR/Flk1↓, 1, VEGFR2/KDR/Flk1↑, 1, p‑VEGFR2/KDR/Flk1↓, 1,

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 3, AQPs↑, 3, pol-AQPs↑, 1, BBB?, 3, BBB↓, 9, BBB↑, 161, BBB↝, 14, BBB∅, 4, CellMemb↑, 6, CLDN1↓, 2, CLDN1↑, 2, CLDN1↝, 1, CLDN3↑, 1, CLDN4↑, 1, CLDN5↓, 1, CLDN5↑, 1, EPR↑, 3, GastroP↑, 15, GLUT1↓, 2, GLUT1↑, 5, GLUT2↑, 2, GLUT3↑, 5, GLUT4↓, 1, GLUT4↑, 10, GlyFlow↑, 3, H+/K+-ATPase↓, 1, IBI↑, 12, LAT↑, 1, MMP↓, 16, MMP↑, 77, MMP⇅, 1, MMP↝, 2, MMP∅, 4, MPT↑, 1, MUC19↓, 1, MUC2↓, 1, MUC5AC↓, 2, Na+↑, 2, Na+↝, 1, NHE3↑, 1, OATPs↓, 3, OCLN↓, 3, OCLN↑, 6, SVCT-2↑, 1, TJ↓, 1, TJ↑, 5, TJ↝, 1, TRPA1↑, 2, TRPC1↓, 1, TRPC1↑, 1, TRPM7↓, 4, TRPM7⇅, 1, TRPM7↝, 1, TRPV1↑, 8, TRPV3↑, 2, VGCC↓, 1, VGCC↑, 2, VGCC⇅, 1, VGCC↝, 1, VGSC↓, 1, VGSC↑, 1, Vm/CMP↑, 2, ZO-1↓, 5, ZO-1↑, 12, ZO-1↝, 1,

Immune & Inflammatory Signaling(tgid=16) ⓘ

AIF1/Iba-1↓, 3, AIM2↓, 2, BALF-Infl↓, 3, BALF-Lym↓, 1, CB2 / CNR2↑, 5, CCL11↓, 2, CD14↑, 1, CD19↑, 1, CD25+↓, 1, CD25+↑, 1, CD4+↑, 8, CD69↓, 1, CD8+↑, 4, cGAS–STING↓, 2, COX1↓, 24, COX1↑, 1, COX2/PTGS2?, 1, COX2/PTGS2↓, 206, COX2/PTGS2↑, 2, COX2/PTGS2∅, 1, CTLA-4↓, 1, CXCc↓, 2, CXCc↑, 1, CXCL1↓, 1, CXCL12↑, 1, CXCL15↓, 1, CXCR2↑, 1, CXCR4↓, 2, DCells↑, 1, Dectin1↑, 1, DR4↓, 1, Eos↓, 8, p‑FcεRI↓, 1, FOXP3↑, 2, GM-CSF↓, 1, GM-CSF↑, 1, HCAR2↑, 1, HMGB1↓, 11, ICAM-1↓, 23, IFN-γ↓, 26, IFN-γ↑, 10, IFN-γ∅, 1, IgE↓, 7, IgG1↓, 1, IL1?, 1, IL1↓, 18, IL1↑, 1, IL10?, 1, IL10↓, 21, IL10↑, 44, IL10∅, 1, IL12↓, 10, IL12↑, 1, IL13↓, 7, IL17↓, 20, IL17↑, 2, IL17∅, 1, IL18↓, 11, IL18↑, 1, IL1RL1/ST2↓, 1, IL1α↓, 2, IL1α∅, 1, IL1β↓, 234, IL1β↑, 2, IL1β∅, 1, IL2↓, 17, IL2↑, 6, IL22↓, 3, IL23↓, 4, IL33↓, 3, IL4↓, 23, IL4↑, 10, IL4∅, 1, IL5↓, 11, IL5↑, 1, IL6?, 3, IL6↓, 258, IL6↑, 11, IL8↓, 45, IL8↑, 1, IL8∅, 1, ILC2↓, 1, Imm↓, 2, Imm↑, 73, Imm⇅, 2, Imm↝, 2, INF-γ↓, 3, Inflam?, 7, Inflam↓, 1001, Inflam↑, 15, Inflam∅, 2, IP-10/CXCL-10↓, 1, IP-10/CXCL-10↑, 1, IRF3↓, 4, LIF↑, 1, LPS↓, 3, LTA/TNF-β↓, 1, LTA/TNF-β↑, 1, M1↓, 1, M2 MC↑, 2, pol-M2 MC↑, 2, Macrophages↓, 1, MCP1/CCL2↓, 26, MCP1/CCL2↑, 2, MCP1/CCL2↝, 1, MCP1/CCL2∅, 1, MCT1↓, 1, MIP‑1α/CCL3↓, 5, MIP2↓, 3, mPGES-1↓, 1, MyD88↓, 10, NeuroI↓, 15, Neut↓, 3, Neut↑, 2, NF-kB?, 1, NF-kB↓, 356, NF-kB↑, 9, p‑NF-kB↓, 9, NK cell↑, 10, NLRP3↓, 91, NLRP3↑, 3, NOD1↓, 1, OSM↑, 1, p‑p50↓, 1, p65↓, 9, p‑p65↓, 3, PAF↓, 2, PAF↑, 2, PAR-2↓, 1, PGD2↓, 1, PGE1↓, 1, PGE2↓, 76, PGE2↑, 3, PSA↓, 2, PSA∅, 1, RAGE↓, 8, RANTES↓, 5, SOCS-3↓, 1, T-Cell↑, 1, Th1 response↓, 2, Th1 response↑, 1, Th17↓, 1, Th2↓, 3, Th2↑, 2, TLR1↓, 3, TLR2↓, 10, TLR3↓, 1, TLR4↓, 43, TLR4↑, 1, TLR4∅, 1, TNF-α?, 1, TNF-α↓, 371, TNF-α↑, 12, TRAF1↓, 1, TRAF6↓, 1, Treg lymp↓, 1, Treg lymp↑, 1, Treg lymp↝, 1, TREM-1↓, 1, TRIF↓, 3, VitD↑, 6, β-HEX↓, 2,

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↑, 2, Astr↓, 2, GFAP↓, 6, MGlio↓, 1, pH↓, 1, pH↑, 1, pH↝, 2, Temp↝, 1, TREM2↓, 1,

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 4, 5HT↑, 34, Ach?, 1, Ach↑, 48, AChE↓, 201, AChE↑, 3, AChE↝, 2, AChE∅, 5, ADAM10↑, 16, ADAM10↝, 2, BChE?, 1, BChE↓, 36, BChE∅, 1, BDNF↓, 4, BDNF↑, 216, BDNF⇅, 1, BDNF↝, 1, BDNF∅, 8, BrainVol↑, 3, BrainVol↝, 1, BrainVol∅, 3, ChAT↑, 22, ChE↓, 1, CHRM1↑, 1, DA↑, 1, DHCR7↑, 1, EndoR↑, 1, GABA↓, 4, GABA↑, 15, GABA↝, 1, GAD1/GAD67↑, 1, GDNF↑, 1, MAOA↓, 17, MAOA↑, 1, MAOA↝, 1, MAOB↓, 8, monoA↓, 1, monoA↑, 3, NGF↑, 15, NMDAR↑, 1, p‑NMDAR↑, 1, NTF3/NT-3↑, 1, PSD95?, 1, PSD95↑, 16, RELN↑, 1, SNAP25↑, 2, SYN1↑, 1, SYN3↓, 1, SYP↑, 2, SYT1↑, 1, TPH1↓, 1, TrkB↓, 2, TrkB↑, 25, TrkB↝, 1, β-Endo↑, 2,

Protein Aggregation(tgid=19) ⓘ

AEP↓, 1, AGEs↓, 16, APOE4↓, 1, APP↓, 27, APP∅, 2, cl‑APP↓, 1, cl‑APP↑, 1, Aβ?, 1, Aβ↓, 334, Aβ↑, 3, Aβ∅, 6, Aβ42↓, 11, BACE/β-secretase↓, 78, BACE/β-secretase↑, 3, BACE/β-secretase↝, 1, IDE↑, 3, NEP↑, 1, PSEN1/PS1↓, 2, PSEN1/PS1↑, 1, PSEN2/PS-2↓, 1, QPCT/QC↓, 1, tau?, 1, tau↓, 63, p‑tau↓, 94, XO↓, 6, XO↝, 1, β-Amyloid↓, 5,

Hormonal & Nuclear Receptors(tgid=20) ⓘ

2/16-OHE1↑, 1, ACE/ACE1↓, 6, ACE2↓, 1, AHR↓, 1, AhR↑, 4, AKR1C3/17β-HSD5/PGF Synthase↑, 1, ARNT↑, 1, BNP↓, 1, cortisol↓, 2, cortisol↑, 1, CYP19↓, 2, DHT↓, 1, DHT↑, 1, END↑, 2, ENL↑, 1, ER(estro)↓, 1, ER(estro)↑, 2, ERβ/ESR2↑, 1, FGF21↑, 4, GLP-1R↑, 1, GPER↑, 1, GR↓, 1, GR↑, 5, GR↝, 1, Leptin↓, 1, PPARα↑, 14, PPARα↝, 1, PPARγ↓, 8, PPARγ↑, 30, p‑PPARγ↓, 1, PR↝, 1, RAAS↓, 1, SHBG↓, 1, testos↓, 1, testos↑, 5, testos?, 1, TSHR↓, 1, VDR↑, 1,

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1, AKR1B1/ALR2↑, 1, AKR1B10↝, 1, BioAv?, 4, BioAv↓, 205, BioAv↑, 343, BioAv⇅, 4, BioAv↝, 154, BioAv∅, 2, BioEnh↑, 36, BioEnh↝, 1, CES2↓, 1, ChemoSen↑, 4, CompStab↓, 2, CompStab↑, 2, CYP1A1↓, 3, CYP1A1↑, 1, CYP1A2↑, 1, CYP1B1↓, 1, CYP2A3/CYP2A6↝, 1, CYP2C19↓, 1, CYP2C6↓, 2, CYP2C6↑, 1, CYP2C8↓, 1, CYP2C9↓, 1, CYP2D1↑, 1, CYP2D6↓, 2, CYP2E1↓, 8, CYP3A2↓, 2, CYP3A2↑, 1, CYP3A4↓, 6, CYP3A4↑, 1, DDS↑, 5, Dose?, 19, Dose↓, 15, Dose↑, 38, Dose⇅, 4, Dose↝, 461, Dose∅, 10, eff?, 2, eff↓, 37, eff↑, 264, eff↝, 35, eff∅, 2, GSTA1↓, 2, GSTA1↑, 13, GSTP1/GSTπ↓, 1, Half-Life?, 2, Half-Life↓, 37, Half-Life↑, 27, Half-Life⇅, 1, Half-Life↝, 82, Half-Life∅, 6, MRP↓, 1, MRP1/ABCC1↓, 1, P-gp/ABCB1↓, 12, P-gp/ABCB1↑, 2, P450↓, 7, P450↑, 2, P450↝, 1, RadioS↑, 1, selectivity↑, 11, selectivity⇅, 1, Synergy↑, 73, TET2↑, 1, UGT1A↓, 1,

Clinical Biomarkers(tgid=22) ⓘ

ALAT?, 1, ALAT↓, 96, ALAT↑, 3, ALAT∅, 4, ALB↑, 4, ALB↝, 1, ALP↓, 22, ALP↑, 2, ALP∅, 1, anemia↓, 1, ascitic↓, 1, AST↓, 95, AST↑, 3, AST∅, 4, BG↓, 9, Bil↓, 5, Bil↑, 2, BloodF↓, 1, BloodF↑, 22, BMD↑, 31, BP?, 1, BP↓, 69, BP↝, 1, BP∅, 3, BUN?, 1, BUN↓, 13, BUN↑, 1, Calcium↑, 2, Calcium↝, 2, CCr / CrCl↓, 1, CCr / CrCl∅, 1, CEA↓, 2, colonLen↑, 1, creat↓, 27, creat↑, 2, CRP↓, 30, EGFR↓, 3, Ferritin↓, 1, Ferritin↑, 2, FEV1↑, 2, HbA1c↓, 1, Hcy/homoC↓, 24, Hcy/homoC↝, 2, HemoG↑, 2, HER2/EBBR2↓, 1, HRV↑, 1, hs-CRP↓, 3, IL6?, 3, IL6↓, 258, IL6↑, 11, IRes↓, 3, IRes↑, 2, IRes↝, 1, LDH↓, 42, LDH↑, 3, LDH∅, 1, Mag↑, 2, NLR↓, 2, NOS2↓, 8, NSE↑, 1, OCN↑, 1, OCN∅, 1, PEF↑, 1, PSA↓, 2, PSA∅, 1, PV↓, 4, RAGE↓, 8, RBC↑, 2, rHR↓, 1, SpO2↑, 1, TG/TAG↓, 6, TMAO↓, 4, TMAO↑, 7, TMAO⇅, 1, TMAO∅, 2, TP53↑, 1, UFR↑, 3, UR↓, 2, Urea↓, 5, VitD↑, 6,

Functional Outcomes(tgid=23) ⓘ

Airway↓, 3, AirwayM↓, 4, Analgesic↑, 5, Anger↓, 1, AntiAge↑, 50, AntiAge⇅, 1, antiAll?, 1, antiAll↑, 77, antiAll∅, 1, AntiArt↑, 24, AntiCan?, 1, AntiCan↓, 4, AntiCan↑, 92, antiCG↑, 1, antiCG↝, 1, antiD↓, 1, AntiDiabetic↓, 4, AntiDiabetic↑, 114, antiM↑, 1, AntiMyl↑, 1, antiNeop↑, 1, antiPs↑, 5, antiPy↑, 1, AntiTum↓, 2, AntiTum↑, 31, ANXi↓, 4, Appetite↓, 1, BDI↓, 1, BOLD↑, 2, Bone Healing↑, 1, BowelM↑, 1, cachexia↓, 1, cachexia↑, 1, cardioP?, 2, cardioP↓, 4, cardioP↑, 261, cardioP⇅, 1, cardioP∅, 1, CardioT↓, 4, chemoP↑, 41, chemoPv↑, 32, ChemoSideEff↓, 1, cognitive?, 3, cognitive↓, 16, cognitive↑, 593, cognitive↝, 9, cognitive?, 1, cognitive∅, 27, cough?, 1, CryoP↑, 2, cytoP↑, 2, DCR∅, 1, diuretic↑, 10, fatigue↓, 6, GFR↓, 1, GFR↑, 1, GFR∅, 1, Hear↑, 1, hepatoP↓, 10, hepatoP↑, 246, IPSS↓, 1, Learn?, 2, Learn↑, 27, memory?, 4, memory↓, 4, memory↑, 411, memory∅, 6, Mood?, 1, Mood↑, 49, Mood⇅, 1, Mood↝, 1, motorD↓, 3, motorD↑, 67, Mucositis↓, 3, MusCon↓, 2, Nausea↓, 1, neuroP?, 4, neuroP↓, 5, neuroP↑, 709, neuroP↝, 1, NMSS↓, 1, NP/CIPN↓, 4, Obesity↓, 52, ORR∅, 1, OS↓, 1, OS↑, 44, Pain↓, 42, PDE4↓, 2, PFS∅, 1, QoL?, 1, QoL↑, 24, QoL∅, 1, radioP↑, 48, RenoP↓, 2, RenoP↑, 92, RenoP↝, 2, Risk↓, 75, Risk↑, 14, Risk↝, 2, Risk∅, 3, RT↓, 2, Sleep↑, 25, Sleep∅, 1, SoreThr?, 1, Strength↓, 1, Strength↑, 15, Stress↓, 10, Stroke↓, 47, Stroke↑, 1, Stroke↝, 1, Tinn↓, 4, toxicity?, 6, toxicity↓, 321, toxicity↑, 37, toxicity⇅, 2, toxicity↝, 76, toxicity∅, 70, UPDRS↓, 1, UPDRSIII∅, 1, Vomit↓, 1, Weight↓, 17, Weight↑, 4, Weight↝, 3, Weight∅, 4, Wound Healing↓, 2, Wound Healing↑, 40,

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1, AntiBio↑, 61, AntiFungal↓, 2, AntiFungal↑, 32, AntiP↓, 1, AntiP↑, 15, AntiViral↑, 44, Bacteria?, 1, Bacteria↓, 137, Bacteria↑, 1, Dectin1↑, 1, Diar↓, 9, Dysb↓, 2, GutMicro↓, 1, GutMicro↑, 124, GutMicro↝, 9, GutMicro∅, 2, Inf↓, 4, insect↑, 1, Sepsis↓, 28,

Ingredients & Constituents(tgid=25) ⓘ

Api↑, 1, CA↑, 1, Catechins↑, 1, FA↑, 1, Fibre↑, 1, Flav↑, 1, GA↑, 1, Ingr?, 2, Ingr↑, 3, Ingr↝, 18, LT↑, 1, Myr↑, 1, Phen↑, 2, Poly↑, 1, QC↑, 2,
Total Targets: 1609

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

Cancer Database Query Results

Pathway results for Effect on Cancer / Diseased Cells:

NA, unassigned(tgid=0) ⓘ

Redox & Oxidative Stress(tgid=1) ⓘ

Metal & Cofactor Biology(tgid=2) ⓘ

Mitochondria & Bioenergetics(tgid=3) ⓘ

Core Metabolism/Glycolysis(tgid=4) ⓘ

Cell Death(tgid=5) ⓘ

Kinase & Signal Transduction(tgid=6) ⓘ

Transcription & Epigenetics(tgid=7) ⓘ

Protein Folding & ER Stress(tgid=8) ⓘ

Autophagy & Lysosomes(tgid=9) ⓘ

DNA Damage & Repair(tgid=10) ⓘ

Cell Cycle & Senescence(tgid=11) ⓘ

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Migration(tgid=13) ⓘ

Angiogenesis & Vasculature(tgid=14) ⓘ

Barriers & Transport(tgid=15) ⓘ

Immune & Inflammatory Signaling(tgid=16) ⓘ

Cellular Microenvironment(tgid=17) ⓘ

Synaptic & Neurotransmission(tgid=18) ⓘ

Protein Aggregation(tgid=19) ⓘ

Hormonal & Nuclear Receptors(tgid=20) ⓘ

Drug Metabolism & Resistance(tgid=21) ⓘ

Clinical Biomarkers(tgid=22) ⓘ

Functional Outcomes(tgid=23) ⓘ

Infection & Microbiome(tgid=24) ⓘ

Ingredients & Constituents(tgid=25) ⓘ

Pathway results for Effect on Normal Cells:

NA, unassigned(tgid=0) ⓘ

Redox & Oxidative Stress(tgid=1) ⓘ

Metal & Cofactor Biology(tgid=2) ⓘ

Mitochondria & Bioenergetics(tgid=3) ⓘ

Core Metabolism/Glycolysis(tgid=4) ⓘ

Cell Death(tgid=5) ⓘ

Kinase & Signal Transduction(tgid=6) ⓘ

Transcription & Epigenetics(tgid=7) ⓘ

Protein Folding & ER Stress(tgid=8) ⓘ

Autophagy & Lysosomes(tgid=9) ⓘ

DNA Damage & Repair(tgid=10) ⓘ

Cell Cycle & Senescence(tgid=11) ⓘ

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Migration(tgid=13) ⓘ

Angiogenesis & Vasculature(tgid=14) ⓘ

Barriers & Transport(tgid=15) ⓘ

Immune & Inflammatory Signaling(tgid=16) ⓘ

Cellular Microenvironment(tgid=17) ⓘ

Synaptic & Neurotransmission(tgid=18) ⓘ

Protein Aggregation(tgid=19) ⓘ

Hormonal & Nuclear Receptors(tgid=20) ⓘ

Drug Metabolism & Resistance(tgid=21) ⓘ

Clinical Biomarkers(tgid=22) ⓘ

Functional Outcomes(tgid=23) ⓘ

Infection & Microbiome(tgid=24) ⓘ

Ingredients & Constituents(tgid=25) ⓘ

Home Page